Journal: Cancer Management and Research
Article Title: Regorafenib-Induced Stress Response Alters the Bioenergetic Profile of Osteosarcoma Cells and Modulates Gene Expression Associated with Metabolic regulation-a Potential Mechanism of Osteosarcoma Treatment-Related Adaptation
doi: 10.2147/CMAR.S562346
Figure Lengend Snippet: Effect of regorafenib at the IC 5 0 concentration on the expression profile of genes associated with cancer-related pathways in MG63 ( a ) and APR1 ( b ) osteosarcoma cell lines. The x-axis of volcano plot represents log 2 (fold regulation) and the y-axis −log 1 0 (p-value). Upregulated genes are marked with red upward arrows, whereas downregulated genes are marked with green downward arrows. Genes consistently up- or downregulated in both MG-63 and APR-1 cells are additionally highlighted with light-red or light-green circles, respectively. Vertical dashed lines indicate the fold-change cutoff used to define differential expression.Genes showing expression changes of at least 2-fold were classified as differentially expressed. Gene expression levels were normalized to those of reference genes ( ACTB , B2M , RPLP0 , and GAPDH ) and calculated using the 2^(-ΔΔCt) method. The reactions for this assay were performed using three independent biological replicates, each processed as one technical replicate.
Article Snippet: Regorafenib activity was analyzed in vitro using a well-established human osteosarcoma cell line, MG63 (ATCC; CRL-1427), and primary APR1 cells established from patient tissue.
Techniques: Concentration Assay, Expressing, Quantitative Proteomics, Gene Expression